Assignee
MACROGENICS INC
US·86 granted patents·65 pending applications·1,894 citations·filing 2003–2025
Top patents by PatentIndex Score
151 records- 0198US8003774B2Identification and engineering of antibodies with variant Fc regions and methods of using sameMACROGENICS INC·Filed 2008·Granted Aug 23, 2011·96 cites·52 claims
- 0298US7355008B2Identification and engineering of antibodies with variant Fc regions and methods of using sameMACROGENICS INC·Filed 2004·Granted Apr 8, 2008·361 cites·22 claims
- 0397US9822181B2Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereofMACROGENICS INC·Filed 2014·Granted Nov 21, 2017·62 cites·32 claims
- 0497US8044180B2FcγRIIB specific antibodies and methods of use thereofMACROGENICS INC·Filed 2008·Granted Oct 25, 2011·52 cites·40 claims
- 0597US7960512B2Identification and engineering of antibodies with variant Fc regions and methods of using sameMACROGENICS INC·Filed 2004·Granted Jun 14, 2011·161 cites·11 claims
- 0697US7786270B2Humanized FcγRIIB-specific antibodies and methods of use thereofMACROGENICS INC·Filed 2007·Granted Aug 31, 2010·55 cites·5 claims
- 0797US7521542B2Humanized FcγRIIB-specific antibodies and methods of use thereofMACROGENICS INC·Filed 2005·Granted Apr 21, 2009·105 cites·8 claims
- 0897US7425619B2FcγRIIB specific antibodies and methods of use thereofMACROGENICS INC·Filed 2003·Granted Sep 16, 2008·156 cites·40 claims
- 0996US10131713B2HER2/neu-specific antibodies and methods of using sameMACROGENICS INC·Filed 2016·Granted Nov 20, 2018·10 cites·20 claims
- 1096US7351803B2CD16A binding proteins and use for the treatment of immune disordersMACROGENICS INC·Filed 2003·Granted Apr 1, 2008·78 cites·18 claims
- 1196US7112439B2Dual expression vector system for antibody expression in bacterial and mammalian cellsMACROGENICS INC·Filed 2004·Granted Sep 26, 2006·78 cites·27 claims
- 1295US11623959B2PD-1-binding molecules and methods of use thereofMACROGENICS INC·Filed 2020·Granted Apr 11, 2023·6 cites·23 claims
- 1395US10711069B2Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibitingMACROGENICS INC·Filed 2017·Granted Jul 14, 2020·7 cites·16 claims
- 1495US10633440B2Multi-chain polypeptide-containing tri-specific binding molecules that specifically bind to multiple cancer antigensMACROGENICS INC·Filed 2015·Granted Apr 28, 2020·11 cites·18 claims
- 1595US10577422B2PD-1-binding molecules and methods of use thereofMACROGENICS INC·Filed 2016·Granted Mar 3, 2020·19 cites·10 claims
- 1695US10160806B2Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereofMACROGENICS INC·Filed 2015·Granted Dec 25, 2018·18 cites·34 claims
- 1795US9896508B2Antibodies reactive with B7-H3 and uses thereofMACROGENICS INC·Filed 2016·Granted Feb 20, 2018·8 cites·12 claims
- 1895US9469692B2HER2/neu-specific antibodies and methods of using sameMACROGENICS INC·Filed 2016·Granted Oct 18, 2016·8 cites·14 claims
- 1995US7718774B2TES7 and antibodies that bind theretoMACROGENICS INC·Filed 2007·Granted May 18, 2010·32 cites·22 claims
- 2094US10787521B2Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereofMACROGENICS INC·Filed 2017·Granted Sep 29, 2020·7 cites·18 claims
- 2194US10647768B2Multi-chain polypeptide-containing tri-specific binding moleculesMACROGENICS INC·Filed 2015·Granted May 12, 2020·19 cites·21 claims
- 2294US9708408B2Methods for the treatment of disease using immunoglobulins having Fc Regions with altered affinities for FcγRactivating and FcγRinhibitingMACROGENICS INC·Filed 2014·Granted Jul 18, 2017·9 cites·10 claims
- 2394US9243069B2HER2/neu-specific antibodies and methods of using the sameMACROGENICS INC·Filed 2014·Granted Jan 26, 2016·13 cites·9 claims
- 2494US7700100B2FcγRIIB fusion proteins and compositions thereofMACROGENICS INC·Filed 2004·Granted Apr 20, 2010·54 cites·4 claims
- 2594US7618628B2CD16A binding proteins and use for the treatment of immune disordersMACROGENICS INC·Filed 2007·Granted Nov 17, 2009·22 cites·23 claims
- 2693US11858991B2LAG-3-binding molecules and methods of use thereofMACROGENICS INC·Filed 2021·Granted Jan 2, 2024·2 cites·18 claims
- 2793US11111299B2CD3-binding molecules capable of binding to human and non-human CD3MACROGENICS INC·Filed 2018·Granted Sep 7, 2021·3 cites·31 claims
- 2893US9441049B2Antibodies reactive with B7-H3 and uses thereofMACROGENICS INC·Filed 2014·Granted Sep 13, 2016·10 cites·11 claims
- 2993US8951517B2Identification and engineering of antibodies with variant Fc regions and methods of using sameMACROGENICS INC·Filed 2013·Granted Feb 10, 2015·19 cites·15 claims
- 3093US7572456B2Humanized antibodies against West Nile Virus and therapeutic and prophylactic uses thereofMACROGENICS INC·Filed 2005·Granted Aug 11, 2009·21 cites·19 claims
- 3192US10150812B2CD3-binding molecules capable of binding to human and non-human CD3MACROGENICS INC·Filed 2017·Granted Dec 11, 2018·9 cites·28 claims
- 3292US10093738B2Covalent diabodies and uses thereofMACROGENICS INC·Filed 2016·Granted Oct 9, 2018·7 cites·15 claims
- 3392US9695236B2BCR-complex-specific antibodies and methods of using sameMACROGENICS INC·Filed 2015·Granted Jul 4, 2017·11 cites·19 claims
- 3492US7838635B2CD16A binding proteins and use for the treatment of immune disordersMACROGENICS INC·Filed 2007·Granted Nov 23, 2010·17 cites·19 claims
- 3592US7776328B2Antibodies that bind to EphA2 and methods of use thereofMACROGENICS INC·Filed 2009·Granted Aug 17, 2010·6 cites·28 claims
- 3691US11421031B2Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereofMACROGENICS INC·Filed 2020·Granted Aug 23, 2022·2 cites·22 claims
- 3791US11028183B2HER2/neu-specific antibodies and methods of using sameMACROGENICS INC·Filed 2018·Granted Jun 8, 2021·3 cites·38 claims
- 3891US9714296B2Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereofMACROGENICS INC·Filed 2015·Granted Jul 25, 2017·7 cites·27 claims
- 3991US9487587B2Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereofMACROGENICS INC·Filed 2014·Granted Nov 8, 2016·9 cites·14 claims
- 4090US9714295B2Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereofMACROGENICS INC·Filed 2015·Granted Jul 25, 2017·6 cites·27 claims
- 4190US7632497B2Engineering Fc Antibody regions to confer effector functionMACROGENICS INC·Filed 2005·Granted Dec 15, 2009·217 cites·42 claims
- 4289US11685781B2Variant CD3-binding domains and their use in combination therapies for the treatment of diseaseMACROGENICS INC·Filed 2019·Granted Jun 27, 2023·4 cites·33 claims
- 4389US11459394B2Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereofMACROGENICS INC·Filed 2018·Granted Oct 4, 2022·4 cites·8 claims
- 4489US11384149B2Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereofMACROGENICS INC·Filed 2019·Granted Jul 12, 2022·4 cites·13 claims
- 4589US10683364B2Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereofMACROGENICS INC·Filed 2017·Granted Jun 16, 2020·3 cites·20 claims
- 4689US8993730B2BCR-complex-specific antibodies and methods of using sameMACROGENICS INC·Filed 2013·Granted Mar 31, 2015·10 cites·33 claims
- 4789US7906327B2Dual expression vector system for antibody expression in bacterial and mammalian cellsMACROGENICS INC·Filed 2006·Granted Mar 15, 2011·9 cites·22 claims
- 4889US2024409661A1Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses ThereofMACROGENICS INC·Filed 2024·Application pending·0 cites
- 4988US11072653B2LAG-3-binding molecules and methods of use thereofMACROGENICS INC·Filed 2016·Granted Jul 27, 2021·4 cites·17 claims
- 5088US10954301B2Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use thereofMACROGENICS INC·Filed 2016·Granted Mar 23, 2021·3 cites·8 claims
Showing the top 50 of 151 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when MACROGENICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →